Polomar Health Services (PMHS) Total Liabilities (2022 - 2026)
Polomar Health Services (PMHS) posted Total Liabilities of $1.9 million for Q2 2026, up 6.19% on a QoQ basis from $1.8 million in Q1 2026, and up 80.45% year-over-year from $1.0 million in Q2 2025.
Analysis
Polomar Health Services (PMHS) Total Liabilities (2022 - 2026) Analysis & Trends
Polomar Health Services has reported Total Liabilities for 5 years, with the latest figure at $1.9 million in Q2 2026.
- On a quarterly basis, Total Liabilities rose 80.45% year-over-year to $1.9 million in Q2 2026; TTM through Jun 2026 was $1.9 million, a 80.45% increase from a year earlier, with the FY2025 full-year figure at $1.6 million, up 19.2% from the prior year.
- Total Liabilities was $1.9 million for Q2 2026 at Polomar Health Services, up from $1.8 million in the prior quarter.
- The five-year high for Total Liabilities was $1.9 million in Q2 2026, with the low at -$207155.0 in Q1 2023.
- Average Total Liabilities over 5 years is $755063.4, with a median of $564509.0 recorded in 2023.
- The sharpest annual moves came in 2023 and 2024: Total Liabilities plunged 77.08% in 2023, then jumped 6454.78% in 2024.
- Over 5 years, Total Liabilities stood at $74715.0 in 2022, then surged by 102.95% to $151635.0 in 2023, then soared by 792.04% to $1.4 million in 2024, then increased by 19.2% to $1.6 million in 2025, then climbed by 16.05% to $1.9 million in 2026.
- The last three Total Liabilities figures came in at $1.9 million (Q2 2026), $1.8 million (Q1 2026), and $1.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 32.10 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 20.78 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 1.99 Bn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 3.74 Bn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 25.60 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 1.78 Bn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 896.90 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 975.61 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 33.31 Mn |
| 10 | Polomar Health Services | 5.66 Mn | 5.48 Mn | 935,916.00 | 1.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.87 Mn |
| Mar 31, 2026 | 1.76 Mn |
| Dec 31, 2025 | 1.61 Mn |
| Sep 30, 2025 | 1.50 Mn |
| Jun 30, 2025 | 1.04 Mn |
| Mar 31, 2025 | 1.67 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | 977,383.00 |
| Jun 30, 2024 | 102,973.00 |
| Mar 31, 2024 | 82,807.00 |
| Dec 31, 2023 | 151,635.00 |
| Sep 30, 2023 | 14,911.00 |
| Jun 30, 2023 | 14,027.00 |
| Mar 31, 2023 | -207,155.00 |
| Dec 31, 2022 | 74,715.00 |
| Sep 30, 2022 | 65,045.00 |